Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer
April 13, 2020 16:30 ET
|
Cellectis Inc.
NEW YORK, April 13, 2020 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited...
Cybrexa Therapeutics Announces Arthur DeCillis, MD as Acting Chief Medical Officer to Support CBX-12’s Entry into the Clinic
March 31, 2020 08:00 ET
|
Cybrexa Therapeutics
NEW HAVEN, Conn., March 31, 2020 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ tumor targeting...
Morphic Announces Appointment of Peter G. Linde, M.D., as Chief Medical Officer
March 17, 2020 08:00 ET
|
Morphic Therapeutic
WALTHAM, Mass., March 17, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious...
Mujtaba Ali-Khan, D.O. Named Chief Medical Officer at HCA Gulf Coast Division
January 21, 2020 10:26 ET
|
HCA Houston Healthcare
Houston, Jan. 21, 2020 (GLOBE NEWSWIRE) -- The HCA Gulf Coast Division has appointed Mujtaba Ali-Khan, D.O. to the position of chief medical officer for HCA Gulf Coast Division. Ali-Khan, who began...
Mujtaba Ali-Khan, D.O. Named Chief Medical Officer at HCA Gulf Coast Division
January 21, 2020 10:26 ET
|
HCA Houston Healthcare
Houston, Jan. 21, 2020 (GLOBE NEWSWIRE) -- The HCA Gulf Coast Division has appointed Mujtaba Ali-Khan, D.O. to the position of chief medical officer for HCA Gulf Coast Division. Ali-Khan, who began...
Rafael Pharmaceuticals Appoints Chief Medical Officer, José Octávio Costa Filho, M.D.
October 30, 2019 09:00 ET
|
Rafael Pharmaceuticals, Inc.
Cranbury, NJ, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced that...
Emerald Bioscience Appoints Chief Medical Officer and Executive Director, Clinical Operations
August 26, 2019 08:30 ET
|
Emerald Bioscience, Inc.
Long Beach, CA, Aug. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Emerald Bioscience, Inc. (OTCQB: EMBI), focused on the development of cannabinoid-based therapeutics to address global medical...
LHC Group Continues Commitment to Clinical Quality With Addition of Tricia Nguyen as Chief Medical Officer
July 01, 2019 06:30 ET
|
LHC Group
LAFAYETTE, La., July 01, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that Tricia Nguyen, MD, has joined the company as executive vice president and chief medical officer...
Nanobiotix nomme un nouveau directeur médical à la suite de son autorisation de mise sur le marché européen
June 04, 2019 02:00 ET
|
Nanobiotix S.A.
NANOBIOTIX NOMME UN NOUVEAU DIRECTEUR MÉDICAL À LA SUITE DE SON AUTORISATION DE MISE SUR LE MARCHÉ EUROPÉEN Experte de l’industrie Biopharmaceutique, le Dr. Edwina Baskin-Bey rejoint...
NANOBIOTIX APPOINTS NEW CHIEF MEDICAL OFFICER AS THE COMPANY EVOLVES AFTER ACHIEVEMENT OF EUROPEAN MARKET APPROVAL
June 04, 2019 02:00 ET
|
Nanobiotix S.A.
NANOBIOTIX APPOINTS NEW CHIEF MEDICAL OFFICER AS THE COMPANY EVOLVES AFTER ACHIEVEMENT OF EUROPEAN MARKET APPROVAL Biopharmaceutical veteran Edwina Baskin-Bey, M.D., joins Nanobiotix as...